Clinical study participation has historically been heavily biased toward specific demographics.

Several people will be invited to enroll in this trial so that it may collect a variety of data about uterine cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

People with uterine cancer who are invited to take part in medical study will benefit from the analysis of the data.

Inclusion Criteria:

• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• Diagnosis of uterine cancer
• No prior treatment for uterine cancer

Exclusion Criteria:

• Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
• Enrolled in another research study
• Inability to provide written informed consent

Uterine cancer patients who are actively considering enrolling in a clinical trial for the said condition, but have not yet completed enrollment and randomization phases.